Improved clinical outcomes with abciximab therapy in acute myocardial infarction: a systematic overview of randomized clinical trials
- 31 March 2004
- journal article
- research article
- Published by Elsevier in American Heart Journal
- Vol. 147 (3) , 457-462
- https://doi.org/10.1016/j.ahj.2003.08.011
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Enoxaparin as Adjunctive Antithrombin Therapy for ST-Elevation Myocardial InfarctionCirculation, 2002
- Comparison of Angioplasty with Stenting, with or without Abciximab, in Acute Myocardial InfarctionNew England Journal of Medicine, 2002
- Platelet Glycoprotein IIb/IIIa Inhibition with Coronary Stenting for Acute Myocardial InfarctionNew England Journal of Medicine, 2001
- Acute Platelet Inhibition With Abciximab Does Not Reduce In-Stent Restenosis (ERASER Study)Circulation, 1999
- Abciximab in the treatment of acute myocardial infarction eligible for primary percutaneous transluminal coronary angioplasty: Results of the glycoprotein receptor antagonist patency evaluation (GRAPE) pilot studyJournal of the American College of Cardiology, 1999
- Randomized, Placebo-Controlled Trial of Platelet Glycoprotein IIb/IIIa Blockade With Primary Angioplasty for Acute Myocardial InfarctionCirculation, 1998
- Six-month angiographic and clinical follow-up of patients prospectively randomized to receive either tirofiban or placebo during angioplasty in the RESTORE trialJournal of the American College of Cardiology, 1998
- Inhibition of platelet-mediated, tissue factor-induced thrombin generation by the mouse/human chimeric 7E3 antibody. Potential implications for the effect of c7E3 Fab treatment on acute thrombosis and "clinical restenosis".Journal of Clinical Investigation, 1996
- Platelet Glycoprotein IIb/IIIa Receptors in Cardiovascular MedicineNew England Journal of Medicine, 1995
- The Pathogenesis of Coronary Artery Disease and the Acute Coronary SyndromesNew England Journal of Medicine, 1992